Current State of Hypertrophic Cardiomyopathy Clinical Trials.
Sign Up to like & getrecommendations! Published in 2019 at "Global heart"
DOI: 10.1016/j.gheart.2019.07.005
Abstract: BACKGROUND Hypertrophic cardiomyopathy (HCM) is a genetic disorder with a very large global burden for which more therapeutic management regimens are required. OBJECTIVES In this study, the authors explore HCM-related clinical trials, determine the shortcomings… read more here.
Keywords: state hypertrophic; hypertrophic cardiomyopathy; hcm; current state ... See more keywords
Titin-Related Dilated Cardiomyopathy: The Clinical Trajectory and the Role of Circulating Biomarkers in the Clinical Assessment
Sign Up to like & getrecommendations! Published in 2021 at "Diagnostics"
DOI: 10.3390/diagnostics12010013
Abstract: Titin truncating variants (TTNtv) are known as the leading cause of inherited dilated cardiomyopathy (DCM). Nevertheless, it is unclear whether circulating cardiac biomarkers are helpful in detection and risk assessment. We sought to assess 1)… read more here.
Keywords: titin related; related dilated; cardiomyopathy clinical; dilated cardiomyopathy ... See more keywords
Catecholamine-induced cardiomyopathy - a clinical case.
Sign Up to like & getrecommendations! Published in 2022 at "Folia medica"
DOI: 10.3897/folmed.64.e63215
Abstract: A 27-year-old patient presented with a 3-month history of episodic headaches and persistently rising blood pressure (up to 240/120). The clinical, laboratory, and instrumental findings (episodes of severe hypertension, increased levels of metanephrine in urine,… read more here.
Keywords: catecholamine induced; induced cardiomyopathy; clinical case; cardiomyopathy clinical ... See more keywords